-
Patients with extensive coronary artery disease (CAD) and left ventricular (LV) dysfunction are at high risk during revascularization.
-
Supraventricular tachycardia (SVT) is known to be associated with troponin leaks and ST-wave depression on ECG, both potential markers of ischemia.
-
In this report, Liu and colleagues describe the electrophysiologic characteristics of atrial tachycardias (AT) that arise from the noncoronary aortic sinus (NCAS).
-
Merlin-timi 36 tested the hypothesis that ranolazine, a recently approved anti-anginal agent, would benefit patients with non-ST-elevation acute coronary syndrome (NSTEACS).
-
Despite impressive reductions in cardiovascular risk in primary and secondary prevention trails with statin therapy, risk does not reach zero.
-
For patients presenting with acute coronary syndromes (ACS), the optimal doses of aspirin and clopidogrel remain unknown.
-
The wearable cardioverter-defibrillator (WCD) is a totally external system that can monitor a patient's cardiac rhythm and automatically treat episodes of ventricular tachycardia (VT) and ventricular fibrillation (VF) when they are detected.
-
Platelet aggregation is an important pathophysiological step in the development of myocardial infarction (MI), and intensive anti-platelet therapy has become a cornerstone of therapy in patients presenting with MI.
-
Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
-